Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Be The Match BioTherapies

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$62M
Portfolio companies 2
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.60
Exits 1
Key employees Soon

Areas of investment

  • Therapeutics
  • Biotechnology
  • Genetics
  • Health Care
  • Manufacturing
Summary

The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Be The Match BioTherapies, startups are often financed by Penn Medicine Co-Investment Fund, Parker Institute for Cancer Immunotherapy, Lilly Asia Ventures. The meaningful sponsors for the fund in investment in the same round are Gilead Sciences, Ping An Ventures, Penn Medicine Co-Investment Fund. In the next rounds fund is usually obtained by Penn Medicine Co-Investment Fund, Gilead Sciences, Westlake Village BioPartners.

Among the most successful fund investment fields, there are Health Care, Biotechnology. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Magenta Therapeutics

The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. The higher amount of exits for fund were in 2018. Deals in the range of 50 - 100 millions dollars are the general things for fund. Comparing to the other companies, this Be The Match BioTherapies performs on 4 percentage points less the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Be The Match BioTherapies:
Typical Co-investors
Be The Match BioTherapies is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Be The Match BioTherapies:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
62 Mile Ventures New York, New York, United States
AwesomenessTV California, Los Angeles, United States
Barinaga & Alberdi -
Czech Venture Capital Association Czech Republic, Prague, Prague
Eleven Bulgaria, Grad Sofiya, Sofia
Enwei Capital China, Shanghai
Frontline Ventures England, London, United Kingdom
Gaozheng Chuangtou Changzhou, China, Zhejiang
HNA Capital Group -
JD Everest China, Hong Kong, Hong Kong Island
Juesheng Investment China, Hangzhou, Zhejiang
Moe Funding LLC Mahwah, New Jersey, United States
Ningbo Huatong Chuangtou China, Ningbo, Zhejiang
OP Corporate Bank -
Side X Side Management -
Tara Health Foundation -
Union Street Media Burlington, United States, Vermont
Vista Media Enterprises -
Winners Canada, Mississauga, Ontario
XBVentures Distrito Federal, Mexico, Mexico City

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Tmunity Therapeutics

Biotechnology
Genetics
Health Care
Manufacturing
Therapeutics
$75M31 Oct 2019 Philadelphia, Pennsylvania, United States

Tmunity Therapeutics

Biotechnology
Genetics
Health Care
Manufacturing
Therapeutics
$35M19 Apr 2018 Philadelphia, Pennsylvania, United States

Magenta Therapeutics

Biotechnology
Medical
Therapeutics
$52M09 Apr 2018 Cambridge, Massachusetts, United States

Tmunity Therapeutics

Biotechnology
Genetics
Health Care
Manufacturing
Therapeutics
$100M23 Jan 2018 Philadelphia, Pennsylvania, United States

Magenta Therapeutics

Biotechnology
Medical
Therapeutics
$50M02 May 2017 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Be The Match BioTherapies?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 62M
Peak activity year 2018
Lead investments 0
Follow on index 0.60
Exits 1
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Tmunity Therapeutics

Biotechnology
Genetics
Health Care
Manufacturing
Therapeutics
$75M31 Oct 2019 Philadelphia, Pennsylvania, United States

Tmunity Therapeutics

Biotechnology
Genetics
Health Care
Manufacturing
Therapeutics
$35M19 Apr 2018 Philadelphia, Pennsylvania, United States

Magenta Therapeutics

Biotechnology
Medical
Therapeutics
$52M09 Apr 2018 Cambridge, Massachusetts, United States

Tmunity Therapeutics

Biotechnology
Genetics
Health Care
Manufacturing
Therapeutics
$100M23 Jan 2018 Philadelphia, Pennsylvania, United States

Magenta Therapeutics

Biotechnology
Medical
Therapeutics
$50M02 May 2017 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: